hist161173To committee on Health, Aging and Long-Term Care. Referred on January 12, 2023.
Relating to licensure requirements.
Submitted by Occupational Therapists Affiliated Credentialing Board.
hist161014Report received from Agency, January 3, 2023. hist161174To committee on Workforce Development and Economic Opportunities. Referred on January 12, 2023.
Relating to continuing education.
Submitted by Occupational Therapists Affiliated Credentialing Board.
hist161015Report received from Agency, January 3, 2023. hist161175To committee on Workforce Development and Economic Opportunities. Referred on January 12, 2023.
Relating to scheduling Serdexmethylphenidate.
Submitted by Controlled Substances Board.
hist161016Report received from Agency, January 3, 2023. hist161176To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to scheduling ten (10) fentanyl related substances.
Submitted by Controlled Substances Board.
hist161017Report received from Agency, January 3, 2023. hist161177To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to scheduling Alfaxalone.
Submitted by Controlled Substances Board.
hist161018Report received from Agency, January 3, 2023. hist161178To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to Excluding 6-beta-Naltrexol.
Submitted by Controlled Substances Board.
hist161019Report received from Agency, January 3, 2023. hist161179To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to scheduling Fospropofol.
Submitted by Controlled Substances Board.
hist161020Report received from Agency, January 3, 2023. hist161180To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to scheduling Embutramide.
Submitted by Controlled Substances Board.
hist161021Report received from Agency, January 3, 2023. hist161181To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to scheduling Perampanel.
Submitted by Controlled Substances Board.
hist161022Report received from Agency, January 3, 2023. hist161182To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to scheduling Lacosamide.
Submitted by Controlled Substances Board.
hist161023Report received from Agency, January 3, 2023. hist161183To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to transferring 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP.
Submitted by Controlled Substances Board.
hist161024Report received from Agency, January 3, 2023. hist161184To committee on Criminal Justice and Public Safety. Referred on January 12, 2023.
Relating to general updates.
Submitted by Department of Veterans Affairs.
hist161025Report received from Agency, January 3, 2023. hist161185To committee on Veterans and Military Affairs. Referred on January 12, 2023.
Relating to the employment and entrepreneurship grants transition program.
Submitted by Department of Veterans Affairs.
hist161026Report received from Agency, January 3, 2023. hist161186To committee on Veterans and Military Affairs. Referred on January 12, 2023.
Relating to telehealth.
Submitted by Department of Health Services.
hist161027Report received from Agency, January 3, 2023. hist161187To committee on Health, Aging and Long-Term Care. Referred on January 12, 2023.
Relating to income, franchise, excise, sales, and use tax provisions and affecting small business.
Submitted by Department of Revenue.
